FTC Judge Rejects Challenge To Illumina's $8B Grail Deal

By Bryan Koenig (September 1, 2022, 1:05 PM EDT) -- A Federal Trade Commission in-house judge has rejected the agency's challenge to Illumina's $8 billion reacquisition of cancer testing outfit Grail, Illumina said Thursday, ending an important chapter in the fight over the already-completed transaction....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!